Metaclipse Therapeutics

This company is developing novel personalized vaccine immunotherapies for cancer.

Launch date

2010

Employees

United States (HQ)

Date	Investors	Amount	Round
Nov 2010	Georgia Research Alliance	$30.0k	Grant
Nov 2011	Georgia Research Alliance	$30.0k	Grant
Apr 2012	Georgia Research Alliance	$40.0k	Grant
Jul 2016	National Institutes of Health National Cancer Institute (NCI)	$2.4m	Grant
Jan 2018	N/A	$1.0m	Seed
Total Funding		AUD5.4m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Metaclipse Therapeutics